Biotech | November 25, 2021
GreenLight Biosciences and Samsung Biologics to build vaccine capacity
The partnership will help advance GreenLight's messenger RNA Covid-19 vaccine candidate
The partnership will help advance GreenLight's messenger RNA Covid-19 vaccine candidate
The companies expect to manufacture over 80 million does of the Covid-19 vaccine in 2022
The company has enabled a transformation across three core areas with an investment target of US $ 150 million
Everest gains access to a clinically validated mRNA platform and a potentially “best-in-class” mRNA COVID-19 vaccine with full technology transfer
The company's discovery services support a wide range of global innovator companies from start-ups to large pharma companies, across a diverse set of therapeutic areas including oncology, CNS, antivirals, and inflammation among others
Sputnik V is a two-dose shot and has an efficacy of 91.6% against COVID 19
Anti-malaria API facility will be operational in 15-18 months
CDSCO to fast-track trials and approval for COVID19 vaccine
The first batch will be shipped to the Gamaleya Center for the quality control
The agreements between the parties involve a total fee of Rs. 8 lakh plus taxes for the grant of the licenses on a non-exclusive basis to SPL
Subscribe To Our Newsletter & Stay Updated
